- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04044183
Managing Pain and Cognitions in Older Adults With Mild Cognitive Impairment or Memory Related Problems and Chronic Pain
Active Brains: Managing Pain and Cognitions in Older Adults With Mild Cognitive Impairment (MCI) or Memory Related Problems (MRP) and Chronic Pain
Study Overview
Status
Intervention / Treatment
Detailed Description
We aim to conduct a pilot randomized controlled trial comparing 2 symptom management programs for older adults with self-reported memory problems and chronic pain: Active Brains 1 Active Brains 2. We will assess how each program may help in improving coping with pain and coping with cognitive functioning. We will explore feasibility, acceptability, and credibility and within group changes in physical, emotional and cognitive functioning.
Each group meets for 8 90 minute sessions over a secure video platform. Each group has 5-8 participants. Participants receive a treatment manual. There are 2 assessment points: baseline, and post program. Assessments involve questionnaires, a walk test, and objective step count with ActiGraphs for 1 week.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male and female patients, age 60 years or older
- Have nonmalignant chronic pain for more than 3 months
- Has MCI or subjective memory related problems
- Able to perform a 6-minute walk test at an accelerated pace
- Owns a smartphone with Bluetooth 4.0
- Willingness and ability to participate in the Active Brains intervention and to comply with the requirements of the study protocol (including weekly sessions and Fitbit use)
- Free of concurrent psychotropic or pain medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic or pain medication for a minimum of 6 weeks and willing to maintain a stable dose
- Cleared by a medical doctor for study participation
- Leads a sedentary lifestyle
Exclusion Criteria:
- Diagnosed with medical illness expected to worsen in the next 6 months
- Serious mental illness or instability for which hospitalization may be likely in the next 6 months
- Current suicidal ideation reported on self-report
- Lifetime history of schizophrenia, bipolar disorder, or other psychotic disorder, or substance dependence
- Current substance use disorder, within the past 6 months
- Practice of yoga/meditation, or other mind-body techniques that elicit the relaxation response, once per week for 45 minutes or more within the last 3 months or less
- Regular use of Fitbit in the last 3 months
- Engagement in regular intensive physical exercise for >30 minute daily
- Unable to walk without use of assistance (e.g., wheelchair, walker)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active Brains
Active Brains uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions, and weekly practice assignments (homework).
The Active Brains sessions reflect a purposeful integration of the three treatment approaches (relaxation methods, stress appraisal & coping, and growth enhancement).
The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions.
Active Brains 1 uses a digital monitoring device (i.e., Fitbit) for recording of physical activity.
|
Active Brains uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions, and weekly practice assignments (homework).
The Active Brains sessions reflect a purposeful integration of the three treatment approaches (relaxation methods, stress appraisal & coping, and growth enhancement).
The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions.
Active Brains 1 uses a digital monitoring device (i.e., Fitbit) for recording of physical activity.
This active comparison condition controls for the effect of time spent, group member support/feedback, and interventionist support/feedback.
The original HEP was adapted to provide population-specific information on chronic pain and MCI/MRP symptoms.
Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight", and "Medical appointments").
The HEP program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition.
The HEP is conducted in the same format as Active Brains-Fitbit but are not taught the mind-body, walking, or cognitive-behavioral skills.
HEP participants are encouraged to set lifestyle goals instead of quota-based walking goals aided by the Fitbit as in the Active Brains-Fitbit condition.
|
|
Placebo Comparator: Active Brains 2
This active comparison condition controls for the effect of time spent, group member support/feedback, and interventionist support/feedback.
The original HEP was adapted to provide population-specific information on chronic pain and MCI/MRP symptoms.
Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight", and "Medical appointments").
The HEP program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition.
The HEP is conducted in the same format as Active Brains-Fitbit but are not taught the mind-body, walking, or cognitive-behavioral skills.
HEP participants are encouraged to set lifestyle goals instead of quota-based walking goals aided by the Fitbit as in the Active Brains-Fitbit condition.
|
Active Brains uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions, and weekly practice assignments (homework).
The Active Brains sessions reflect a purposeful integration of the three treatment approaches (relaxation methods, stress appraisal & coping, and growth enhancement).
The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions.
Active Brains 1 uses a digital monitoring device (i.e., Fitbit) for recording of physical activity.
This active comparison condition controls for the effect of time spent, group member support/feedback, and interventionist support/feedback.
The original HEP was adapted to provide population-specific information on chronic pain and MCI/MRP symptoms.
Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight", and "Medical appointments").
The HEP program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition.
The HEP is conducted in the same format as Active Brains-Fitbit but are not taught the mind-body, walking, or cognitive-behavioral skills.
HEP participants are encouraged to set lifestyle goals instead of quota-based walking goals aided by the Fitbit as in the Active Brains-Fitbit condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Client Satisfaction Questionnaire 3-Item (CSQ-3): Number of Participants With Scores Above and Below Scale Midpoint
Time Frame: 8 Weeks
|
Items are summed to generate a total score; scores range from 3 to 12, with higher values indicating higher satisfaction
|
8 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Montreal Cognitive Assessment (MoCA)
Time Frame: 0 Weeks, 8 Weeks
|
Assesses several cognitive domains and detection of mild cognitive impairment (MCI), with scores ranging from 0-30 and lower scores indicating greater cognitive decline
|
0 Weeks, 8 Weeks
|
|
Measure of Current Status (MOCS-A)
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's self-reported perceived stress self-management skills, with items ranging from 0-4 and a total score ranging from 0-52, and higher scores reflecting more usage of stress self-management skills
|
0 Weeks, 8 Weeks
|
|
Numerical Rating Scale
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's pain at rest and with activity using a Likert scale with 0 being no pain and 10 being the worst possible pain
|
0 Weeks, 8 Weeks
|
|
The Cognitive and Affective Mindfulness Scale - Revised (CAMS-R)
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's broad conceptualization of mindfulness, items range from 1-4 and scores range from 12-48, with higher values reflecting higher levels of mindfulness
|
0 Weeks, 8 Weeks
|
|
The Gratitude Questionnaire (GQ-6)
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's proneness to experience gratitude in daily life, with items ranging from 1-7, total scores ranging from 6-24, and a higher score indicating greater amount of gratitude
|
0 Weeks, 8 Weeks
|
|
PROMIS Physical Function
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's capability rather than performance of physical activities, with items ranging from 1-4, and total scores ranging from 8-40, with a higher score reflecting greater physical function
|
0 Weeks, 8 Weeks
|
|
Pain Catastrophizing Scale (PCS)
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's pain experience, with items ranging from 0-4, and total scores ranging from 0-52, with higher scores indicating higher levels of pain catastrophizing
|
0 Weeks, 8 Weeks
|
|
UCLA Loneliness Scale
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's feelings of loneliness and social isolation and items range from 0-3, with a higher score reflecting greater feelings of loneliness, with total scores ranging from 0-24
|
0 Weeks, 8 Weeks
|
|
Pain Self Efficacy Questionnaire (PSEQ)
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's confidence to do various activities despite their pain, with items ranging from 0-6, and a higher score showing greater levels of confidence with pain self-efficacy, with total scores ranging from 0-60
|
0 Weeks, 8 Weeks
|
|
Tampa Kinesiophobia Scale
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's fear of movement, with items ranging from 1-4, and a total scores ranging from 17-68, and higher scores indicating higher levels of fear of movement
|
0 Weeks, 8 Weeks
|
|
Chronic Pain Acceptance Questionnaire
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's acceptance of chronic pain, with scores ranging from 0-6, with the total score ranging from 0-48, and higher scores indicating higher levels of acceptance of chronic pain
|
0 Weeks, 8 Weeks
|
|
Self-Compassion Scale (SCS)
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's amount of self-compassion, with items ranging from 1-5, and total scores ranging from 12-60 and higher scores indicating higher levels of self-compassion
|
0 Weeks, 8 Weeks
|
|
Proportion of Participants With Valid Digital Monitoring Device Wear
Time Frame: 0 Weeks, 8 Weeks
|
The proportion of patients with valid ActiGraph (digital monitoring device) wear for greater than or equal to 6 days (7+ hr/day) at baseline and 5 days at post test
|
0 Weeks, 8 Weeks
|
|
Proportion of Participants With Valid Adherence to Homework
Time Frame: 0 Weeks, 8 Weeks
|
Proportion of participants completing at least 5 out of 7 days of homework assigned throughout the study
|
0 Weeks, 8 Weeks
|
|
Rate of Interventionist's Delivering the Programs by Following the Established Session Topics and Skills
Time Frame: 0 Weeks, 8 Weeks
|
Percentage of audio recordings, progress notes, and checklists that were completed with 100% of content delivered for each session
|
0 Weeks, 8 Weeks
|
|
Percentage of Missing or Low Reliability Measures (Feasibility of Quantitative Measures)
Time Frame: 0 Weeks, 8 Weeks
|
Percentage of questionnaires that were entirely missing in >25% of participants and/or had an internal reliability below .70
|
0 Weeks, 8 Weeks
|
|
Proportion of Participants Using Rescue (Non-Narcotic) Analgesics
Time Frame: 0 Weeks
|
Single-item question on demographics form indicating whether participant used rescue (non-narcotic) analgesics at baseline
|
0 Weeks
|
|
Proportion of Participants Using Narcotic Analgesics
Time Frame: 0 Weeks
|
Single-item question on demographics form indicating whether participant used narcotic analgesics at baseline
|
0 Weeks
|
|
Credibility and Expectancy Questionnaire (CEQ): Number of Participants With Scores Above and Below Scale Midpoint
Time Frame: 0 Weeks
|
Number of participants rating expectations and believed credibility for the program above and below the scale midpoint, with higher ratings indicating more belief that the program is logical and will help with the intended outcome
|
0 Weeks
|
|
Godin Leisure-Time Exercise Questionnaire
Time Frame: 0 Weeks, 8 Weeks
|
Rate of participant's leisure time and physical activity levels by indicating how many days per week are spent doing the activity for more than 15 minutes.
Scores range from 0-119, with higher scores indicating greater levels of activity.
|
0 Weeks, 8 Weeks
|
|
The Measurement of Everyday Cognition (eCog)
Time Frame: 0 Weeks, 8 Weeks
|
Rate of participant's cognitively mediated functional abilities, with items ranging from 1-5.
Total scores are an average of the items (range = 1-5), with higher scores indicating greater cognitive decline.
|
0 Weeks, 8 Weeks
|
|
WHO Disability Assessment Schedule 2.0
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's health and disability, with items ranging from 0-4, total scores ranging from 0-100, and higher scores reflecting greater disability
|
0 Weeks, 8 Weeks
|
|
PROMIS Emotional Support
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's perceived feelings of being cared and values for as an individual, with items ranging from 1-5.
Items are normed to T-scores (mean = 50, standard deviation = 10), with higher T-scores indicating higher perceived social support.
|
0 Weeks, 8 Weeks
|
|
T-Score for PROMIS Depression
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's depressive symptoms, with items ranging from 1-5.
Items are normed to T-scores (mean = 50, standard deviation = 10), with higher T-scores indicating higher depression.
|
0 Weeks, 8 Weeks
|
|
T-Score for PROMIS Anxiety
Time Frame: 0 Weeks, 8 Weeks
|
Rate of a participant's fear, anxious, hyper arousal, and somatic symptoms pertaining to arousal.
Items are normed to T-scores (mean = 50, standard deviation = 10), with higher T-scores indicating higher anxiety.
|
0 Weeks, 8 Weeks
|
|
ActiGraph Average Steps
Time Frame: 0 weeks, 8 weeks
|
Participants wore a ActiGraph accelerometer around their waist for 8 days to measure their daily average step count.
|
0 weeks, 8 weeks
|
|
Six-Minute Walk Test (6MWT)
Time Frame: 0 weeks, 8 weeks
|
The Six-Minute Walk Test (6MWT) measures the distances participants can walk at an accelerated pace in meters over a 6-minute span.
|
0 weeks, 8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ana-Maria Vranceanu, PhD, Massachusetts General Hospital
Publications and helpful links
General Publications
- Doorley JD, Mace RA, Popok PJ, Grunberg VA, Ragnhildstveit A, Vranceanu AM. Feasibility Randomized Controlled Trial of a Mind-Body Activity Program for Older Adults With Chronic Pain and Cognitive Decline: The Virtual "Active Brains" Study. Gerontologist. 2022 Aug 12;62(7):1082-1094. doi: 10.1093/geront/gnab135.
- Mace RA, Doorley JD, Popok PJ, Vranceanu AM. Live Video Adaptations to a Mind-Body Activity Program for Chronic Pain and Cognitive Decline: Protocol for the Virtual Active Brains Study. JMIR Res Protoc. 2021 Jan 4;10(1):e25351. doi: 10.2196/25351.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018P002152
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
University Rovira i VirgiliMinisterio de Ciencia e Innovación, SpainNot yet recruitingChronic Post-operative Pain | Chronic Postsurgical Pain | Chronic Post-surgical Pain | Chronic Postoperative PainSpain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Bjorn AngKarolinska Institutet; The Swedish Research Council; Göteborg University; Forte; Dalarna...Not yet recruitingPain Management | Pain, Chronic | Chronic Pain, WidespreadSweden
-
University of FaisalabadNot yet recruiting
-
Universidade do Vale do ParaíbaCAPES Foundation - Ministry of Education, Brazil.Enrolling by invitationChronic Low Back Pain | Chronic Shoulder Pain | Chronic Knee PainBrazil
-
Vastra Gotaland RegionCompletedPain, Chronic | Widespread Chronic PainSweden
-
Washington D.C. Veterans Affairs Medical CenterRecruitingChronic Back Pain | Chronic Pain (back / Neck)United States
-
Connecticut Children's Medical CenterRecruitingChronic Pain | Pain, Chronic | Chronic Pain SyndromeUnited States
-
The University of Texas Health Science Center,...RecruitingJoint Pain | Chronic Knee Pain | Chronic Pain (Back / Neck) | Chronic Pain ManagementUnited States
-
Pamukkale UniversityCompletedElderly | Pain, Chronic | Chronic Knee PainTurkey
Clinical Trials on Active Brains 1
-
Massachusetts General HospitalActive, not recruitingChronic Pain | Physical Activity | Mild Cognitive Impairment | Older AdultsUnited States
-
University of British ColumbiaMitacsCompleted
-
University of OregonCompletedSchool ReadinessUnited States
-
Children's Hospital Medical Center, CincinnatiActive, not recruiting
-
Novozymes A/SAnalyze & RealizeCompletedLactose IntoleranceGermany
-
Seoul National University HospitalUnknownTinnitusKorea, Republic of
-
Next Life SciencesRecruitingMale Contraception | Semen Volume | Sperm MotilityUnited States
-
Lund UniversityVinnova; Antidiabetic Food Centre AFCCompleted
-
Eisai Inc.CompletedHealthy | Drug AbuseCanada
-
Radicle ScienceNot yet recruitingHydrationUnited States